The present invention relates to novel compounds of formula (I) and (II), compositions comprising compounds of formula (II) and their use as contrast agents in magnetic resonance (MR) imaging (MRI) and MR spectroscopy (MRS).
[EN] MULTIMERIC MAGENTIC RESONANCE CONTRAST AGENTS<br/>[FR] PRODUITS DE CONTRASTE DE RÉSONANCE MAGNÉTIQUE POUR MULTIMÈRES
申请人:GE HEALTHCARE AS
公开号:WO2007064227A1
公开(公告)日:2007-06-07
[EN] The present invention relates to novel compounds of formula (I) and (II), compositions comprising compounds of formula (II) and their use as contrast agents in magnetic resonance (MR) imaging (MRI) and MR spectroscopy (MRS). [FR] La présente invention concerne des composés novateurs des formules (I) et (II), des compositions comprenant les composés de la formule (II) et leur utilisation comme produits de contraste dans l'imagerie par résonance magnétique (IRM) et la spectroscopie par résonance magnétique (SRM).
作者:Anna B. Aletti、Salvador Blasco、Savyasachi J. Aramballi、Paul E. Kruger、Thorfinnur Gunnlaugsson
DOI:10.1016/j.chempr.2019.06.023
日期:2019.10
Using solution and solid-state analyses, we demonstrate that the tripodal N-methylated(1,3,5-benzene-tricarboxamide)-tris(phenylurea) BTA ligands, possessing urea functionalities in the meta position, are able to form extended self-assembly 2D networks via hydrogen bonding templated by sulfate (SO42–). The divergence of the urea binding sites confers a propeller-like conformation to the ligands and